Live feed20:00:32·4hINSIDERFilingvia QuantisnowChief Research Officer Rote William E. converted options into 4,250 shares and sold $121,434 worth of shares (2,763 units at $43.95) as part of a pre-agreed trading plan, increasing direct ownership by 1% to 115,474 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.TVTX· Travere Therapeutics Inc.Health CareOriginal source